Bishai; William R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bishai; William R..The latest application filed is for "methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses".

Company Profile

7.5.13

Bishai; William R. - Baltimore MD
Bishai; William R. - Towson MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Producing Aggregate-free Monomeric Diphtheria Toxin Fusion Proteins And Therapeutic Uses App 20220204579 - Bishai; William R. ; et al.	2022-06-30
Methods Of Treating Or Preventing Cancer With An Agent That Depletes Tregs And A Checkpoint Inhibitor App 20220023395 - Bishai; William R. ; et al.	2022-01-27
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses Grant 11,203,626 - Bishai , et al. December 21, 2	2021-12-21
Methods of Treating Cancer Using Bacteria Expressing c-di-AMP App 20210145896 - Bishai; William R. ; et al.	2021-05-20
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses Grant 10,988,512 - Bishai , et al. April 27, 2	2021-04-27
Recombinant Therapeutic Interventions For Cancer App 20210024940 - Bishai; William R. ; et al.	2021-01-28
Methods of treating cancer using bacteria expressing c-di-AMP Grant 10,842,828 - Bishai , et al. November 24, 2	2020-11-24
Methods Of Producing Aggregate-free Monomeric Diphtheria Toxin Fusion Proteins And Therapeutic Uses App 20200157166 - Bishai; William R. ; et al.	2020-05-21
Methods of Producing Aggregate-Free Monomeric Diphtheria Toxin Fusion Proteins and Therapeutic Uses App 20190071472 - BISHAI; William R. ; et al.	2019-03-07
Methods of treating cancer using bacteria expressing c-di-AMP App 20190030091 - Bishai; William R. ; et al.	2019-01-31
Bacteria over-expressing c-di-AMP and therapeutic methods Grant 10,130,663 - Bishai , et al. November 20, 2	2018-11-20
Bacteria Over-expressing C-di-amp And Therapeutic Methods App 20180028577 - Bishai; William R. ; et al.	2018-02-01
Inhibitors Of Drug-resistant Mycobacterium Tuberculosis App 20170044100 - Bishai; William R. ; et al.	2017-02-16
Methods for treatment of bacterial infections Grant 9,273,341 - Lamichhane , et al. March 1, 2	2016-03-01
Methods For Treatment Of Bacterial Infections App 20140342364 - Lamichhane; Gyanu ; et al.	2014-11-20
Methods For Treatment Of Bacterial Infections App 20120115835 - Lamichhane; Gyanu ; et al.	2012-05-10
Mycobacterium Tuberculosis Persistance Genes App 20080241182 - Jain; Sanjay K. ; et al.	2008-10-02
Hollow fiber technique for in vivo study of cell populations App 20060182685 - Bishai; William R. ; et al.	2006-08-17

Company Registrations

NCAGE Code	47WG6	BISHAI WILLIAM R
NCAGE Code	4LNK5	BISHAI, WILLIAM R!DBA USE CAGE CODE 47WG6 FOR!CATALOGING
NCAGE Code	4LNK6	BISHAI, WILLIAM R!DBA USE CAGE CODE 47WG6 FOR!CATALOGING
CAGE Code	47WG6	BISHAI, WILLIAM R
CAGE Code	4LNK5	BISHAI, WILLIAM R USE CAGE CODE 47WG6 FOR CATALOGING
CAGE Code	4LNK6	BISHAI, WILLIAM R USE CAGE CODE 47WG6 FOR CATALOGING

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.